Design and synthesis of N-aryl-2-trifluoromethyl-quinazoline-4-amine derivatives as potential Werner-dependent antiproliferative agents
Molecular Diversity · 2025
DOI: 10.1007/s11030-024-10844-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Diversity, 2025. Verfasst von Huimin Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Quinazolines, Drug Design, Werner Syndrome Helicase. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Natural Science Foundation of Guizhou Medical University, Natural Science Foundation of Guizhou province, The Science and Technology Planning Project of Guizhou Province.
Abstract (Originalsprache)
To discover new Werner (WRN) helicase inhibitors, a series of N-aryl-2-trifluoromethyl-quinazoline-4-amine derivatives were designed and synthesized through a structural optimization strategy, and the anticancer activities of 25 new target compounds against PC3, K562, and HeLa cell lines were evaluated by the MTT assay. Some of these compounds exhibited excellent inhibitory activity against three different cancer cell lines. Compounds 6a, 8i, and 13a showed better antiproliferative activity against K562 cells, with IC50 values of 3871.5, 613.6 and 134.7 nM, respectively, than did paclitaxel (35.6 nM), doxorubicin (2689.0 nM), and NSC 617145 (20.3 nM). To further verify whether the antiproliferative activity of these compounds is dependent on WRN, PC3 cells overexpressing WRN (PC3-WRN) were constructed to further study their antiproliferative potency in vitro, and the inhibition ratio and IC20 values showed that compounds 6a, 8i, and 13a were more sensitive to PC3-WRN than were the control group cells (PC3-NC). The IC20 ratios of compounds 6a, 8i, and 13a to PC3-NC and PC3-WRN were 94.3, 153.4 and 505.5, respectively. According to the docking results, the compounds 6a, 8i, and 13a overlapped well with the binding pocket of 6YHR. Further study demonstrated that among the tested compounds, 13a was the most sensitive to PC3-WRN. In summary, our research identified a series of N-aryl-2-trifluoromethyl-quinazoline-4-amine derivatives as potential WRN-dependent anticancer agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China.
- Natural Products Research Center of Guizhou Province, Guiyang, 550014, China.
- School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, 550025, China.
- College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, 550025, China.
- State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China. xgc0707@163.com.
- Natural Products Research Center of Guizhou Province, Guiyang, 550014, China. xgc0707@163.com.
Förderung
- Natural Science Foundation of Guizhou Medical University
- Natural Science Foundation of Guizhou province
- The Science and Technology Planning Project of Guizhou Province
- Guizhou province "Hundred" level innovative talent training project
- the National Natural Science Foundations of China
- the Department of Science and Technology of Guizhou Province
- Guizhou province “Hundred” level innovative talent training project
Zitieren
APA
Li, H., Yu, J., Yu, G., Cheng, S., Wu, H., Wei, J., You, C., Liu, K., Wang, M., Meng, X., Xu, G., Luo, H., & Xu, B. (2025). Design and synthesis of N-aryl-2-trifluoromethyl-quinazoline-4-amine derivatives as potential Werner-dependent antiproliferative agents. Molecular Diversity. https://doi.org/10.1007/s11030-024-10844-6
Vancouver
Li H, Yu J, Yu G, Cheng S, Wu H, Wei J, et al. Design and synthesis of N-aryl-2-trifluoromethyl-quinazoline-4-amine derivatives as potential Werner-dependent antiproliferative agents. Molecular Diversity. 2025. doi:10.1007/s11030-024-10844-6
BibTeX
@article{Li2025,
author = {Li, Huimin and Yu, Jia and Yu, Gang and Cheng, Sha and Wu, Hui and Wei, Jiaomei and You, Chang and Liu, Kun and Wang, Menghan and Meng, Xueling and Xu, Guangcan and Luo, Heng and Xu, Bixue},
title = {Design and synthesis of N-aryl-2-trifluoromethyl-quinazoline-4-amine derivatives as potential Werner-dependent antiproliferative agents},
journal = {Molecular Diversity},
year = {2025},
doi = {10.1007/s11030-024-10844-6}
}
EUVIMED